EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Tri ethylene melamine an initiator of 2 stage carcinogenesis in mouse skin which lacks the potential of a complete carcinogen






Cancer Letters 21(1): 37-42

Tri ethylene melamine an initiator of 2 stage carcinogenesis in mouse skin which lacks the potential of a complete carcinogen

The dorsal skin of female CD-1 mice was treated with triethylenemelamine (TEM) to determine whether this agent acted either as a complete carcinogen or as an initiator of carcinogenesis. A dose of 0.01-1.0 .mu.mol of TEM applied 1/wk for 32 wk to the skin of the backs of mice did not produce any detectable tumors. A dose of 2.5 .mu.mol applied 1/wk over the same period produced only a single papilloma in a group of 20 mice. When mice were treated with a single dose of 1 .mu.mol of TEM followed by promotion with 12-O-tetradecanoylphorbol-13-acetate (TPA) twice a week, 88% of the mice produced papillomas after 28 wk. Using the same protocol, a single application of hexamethylmelamine (HMM), pentamethylmelamine (PMM), or melamine followed by promotion with TPA had no significant tumor initiating activity. TEM may act primarily as an initiator of 2-stage carcinogenesis.


Accession: 006840005



Related references

Perrella, F.W.; Boutwell, R.K., 1983: Triethylenemelamine: an initiator of two-stage carcinogenesis in mouse skin which lacks the potential of a complete carcinogen. The dorsal skin of female CD-1 mice was treated with triethylenemelamine (TEM) to determine whether this agent acted either as a complete carcinogen or as an initiator of carcinogenesis. A dose of 0.01-1.0 mumol of TEM applied once a week for 32 w...

Takahashi, M.; Furukawa, F.; Miyakawa, Y.; Sato, H.; Hasegawa, R.; Hayashi, Y., 1986: 3-Amino-1-methyl-5H-pyrido[4,3-b]-indole initiates two-stage carcinogenesis in mouse skin but is not a complete carcinogen. In two separate experiments, 2.0 mg of 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) was applied to the back of female CD-1 mice twice weekly for 5 weeks followed by application of 2.5 micrograms of 12-O-tetradecanoyl-phorbol-13-acetate (TPA)...

Chiba, M.; Maley, M.A.; Klein-Szanto, A.J., 1986: Sequential study of gamma-glutamyltransferase during complete and two-stage mouse skin carcinogenesis. The histochemical pattern of gamma-glutamyltransferase (GGT) was studied in benign and malignant tumors produced by two different experimental protocols, two-stage carcinogenesis and complete carcinogenesis. Six percent of all papillomas produced...

Jiang, H.; Yamamoto, S.; Kato, R., 1994: Inhibition of two-stage skin carcinogenesis as well as complete skin carcinogenesis by oral administration of TMK688, a potent lipoxygenase inhibitor. 1-([5'-(3''-methoxy-4''-ethoxycarbonyloxyphenyl)-2',4'- pentadienoyl]aminoethyl)-4-diphenylmethoxypiperidine (TMK688) is a potent and orally active 5-lipoxygenase inhibitor having anti-histamine activity in its m...

Jiang, H.; Yamamoto, S.; Kato, R., 1994: Inhibition of two-stage skin carcinogenesis as well as complete skin carcinogenesis by oral administration of RMK688, a potent lipoxygenase inhibitor. 1-((5'-(3"-methoxy-4"-ethoxycarbonyloxyphenyl)-2',4'-penta-dienoyl)aminoethyl )4-diphenylmethoxypiperidine (TMK688) is a potent and orally active 5-lipoxygenase inhibitor having with a potency similar to its inhibiting 5-l...

Moon, D.C.; Nakayama, J.; Urabe, A.; Terao, H.; Kinoshita, N.; Hori, Y., 1992: Immunohistochemical characterization of cellular infiltrates in epidermal tumors induced by two-stage and complete chemical carcinogenesis in mouse skin. We investigated the population and pattern of the infiltrated cells in both benign and malignant epidermal tumors which were induced chemically with benzo(a)pyrene (B(a)P) in murine skin. In benign papillomas, which were evolved by a two stage car...

Armuth, V.; Berenblum, I., 1981: The effect of caffeine on two-stage skin carcinogenesis and on complete systemic carcinogenesis. A single large dose of caffeine (100 microgram/g body weight) was injected at different time in relation to urethan initiation for skin tumorigenesis, topical anthranil treatment serving as promotor. Caffeine significantly increased papilloma inci...

Armuth V.; Berenblum I., 1981: The effect of caffeine on 2 stage skin carcinogenesis and complete systemic carcinogenesis. A single large dose of caffeine (100 .mu.g/g body wt) was injected [in mice] at different times in relation to urethan initiation for skin tumorigenesis, topical anthranil treatment serving as promoter. Caffeine significantly increased papilloma i...

Reddy, A.L.; Fialkow, P.J., 1988: Influence of dose of initiator on two-stage skin carcinogenesis in BALB/c mice with cellular mosaicism. We examined the effects of initiation with different doses of 7,12-dimethylbenz[a]anthracene (DMBA) on two-stage skin carcinogenesis in BALB/c mice. The induction of skin papillomas and their sequential tumor progression were followed by determina...

Craig A.M.; Bowden G.T.; Chambers A.F.; Spearman M.A.; Greenberg A.H.; Wright J.A.; Mcleod M.; Denhardt D.T., 1990: Secreted phosphoprotein messenger rna is induced during multi stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts. Secreted phosphoprotein l (SPP), also known as 2ar, osteopontin, 44-kDa bone phosphoprotein, bone is sialoprotein l, and transformation-related phosphoprotein, is a 41.5-kDa glycosylated phosphoprotein secreted by many mammalian cell lines and exp...